The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Kobi William G since 2008.
The trader's CIK number is 1243285.
At the time of the last reporting, Kobi William G was the Director of Synovis Life Technologies Inc. (stock ticker symbol SYNO).
Also see all insider trading activities at Synovis Life Technologies Inc.
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2011 | SYNO | 0 | $0 | 10,000 | $208,470 | 10,000 | $75,000 |
2010 | SYNO | 0 | $0 | 25,000 | $379,187 | 24,000 | $169,500 |
2009 | SYNO | 0 | $0 | 10,500 | $151,481 | 10,000 | $60,000 |
2008 | SYNO | 0 | $0 | 8,500 | $164,965 | 7,000 | $42,000 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2011-04-01 | SYNO | Option Ex | 10,000 | 7.50 | 75,000 |
2011-04-01 | SYNO | Sale | 10,000 | 20.85 | 208,470 |
2010-10-04 | SYNO | Option Ex | 5,000 | 7.50 | 37,500 |
2010-10-04 | SYNO | Sale | 5,000 | 14.62 | 73,085 |
2010-06-08 | SYNO | Option Ex | 5,000 | 7.50 | 37,500 |
2010-06-08 | SYNO | Sale | 6,000 | 14.56 | 87,342 |
2010-03-24 | SYNO | Sale | 3,000 | 15.62 | 46,863 |
2010-03-19 | SYNO | Sale | 11,000 | 15.63 | 171,897 |
2010-03-19 | SYNO | Option Ex | 14,000 | 6.75 | 94,500 |
2009-12-08 | SYNO | Sale | 2,000 | 12.50 | 25,000 |
2009-09-21 | SYNO | Option Ex | 10,000 | 6.00 | 60,000 |
2009-09-21 | SYNO | Sale | 7,000 | 13.92 | 97,419 |
2009-06-08 | SYNO | Sale | 1,500 | 19.38 | 29,062 |
2008-12-11 | SYNO | Sale | 2,000 | 14.80 | 29,610 |
2008-09-03 | SYNO | Sale | 5,000 | 22.16 | 110,790 |
2008-09-03 | SYNO | Option Ex | 7,000 | 6.00 | 42,000 |
2008-03-03 | SYNO | Sale | 1,500 | 16.38 | 24,565 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kobi William G (Director of Synovis Life Technologies Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.